CRISPR Therapeutics AG
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Zug
CRSP chart
What traders are saying about $CRSP
Latest postsCRISPR Therapeutics AG news
- Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
Yahoo Finance ·
- Form 4 CRISPR Therapeutics AG: James R. Kasinger (General Counsel and Secretary) For: 22 September
Investing.com India ·
- CRISPR Therapeutics AG (CRSP) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- NTV Asset Management LLC Acquires 61,443 Shares of CRISPR Therapeutics AG $CRSP
MarketBeat ·
- Learn Why The Bull Case For CRISPR Therapeutics Stock Could Change Following CFO Change
Yahoo Finance ·
- CRISPR Therapeutics (CRSP) Promotes Andrew Silver To CFO As Raju Prasad Resigns
Yahoo Finance ·
- Forget Casgevy: CRISPR Therapeutics' Heart-Disease Data Could Matter More
fool.com ·
- CRISPR Therapeutics AG (CRSP) Options Chain - Yahoo Finance
Yahoo! Finance Canada ·
- Crispr Therapeutics Stock Price Forecast. Should You Buy CRSP?
StockInvest.us ·
- CRISPR Therapeutics AG Estimates – NASDAQ:CRSP
TradingView ·
- Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
Yahoo Finance ·
- The Outlook of CRISPR Therapeutics Stock Does Not Look Strong After Its CFO Resigns
barchart.com ·
CRISPR Therapeutics AG key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.5M | $37.3M | $371.2M | $1.2M |
| Net income | -$581.6M | -$366.3M | -$153.6M | -$650.2M |
| Diluted EPS | $-6.47 | $-4.34 | $-1.94 | $-8.36 |
| Total assets (year end) | $2.27B | $2.24B | $2.23B | $2.24B |
| Cash and equivalents (year end) | $347.6M | $298.3M | $389.5M | $211.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About CRISPR Therapeutics AG
- Ticker
- CRSP (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Zug
- Incorporated in
- Switzerland
- Fiscal year end
- December 31
- SEC CIK
- 1674416
- Former names
- CRISPR Therapeutics AG
Frequently asked questions
What exchange is CRISPR Therapeutics AG listed on?
CRISPR Therapeutics AG trades on the Nasdaq under the ticker symbol CRSP.
What industry is CRISPR Therapeutics AG in?
CRISPR Therapeutics AG is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is CRISPR Therapeutics AG headquartered?
CRISPR Therapeutics AG's business address on file with the SEC is in Zug.
When does CRISPR Therapeutics AG's fiscal year end?
CRISPR Therapeutics AG's fiscal year ends on December 31.
How much revenue did CRISPR Therapeutics AG report?
CRISPR Therapeutics AG reported $3.5M in revenue for calendar year 2025, according to its SEC filings.